Prognostic implication of SYT-SSX fusion type in synovial sarcoma: A multi-institutional retrospective analysis in JapanSatoshi Takenaka, Hideki Yoshikawa, Nobuyuki Hashimoto et al.|Oncology Reports|2008Cited by 60
Crisscross CTL Induction by SYT-SSX Junction Peptide and Its HLA-A*2402 Anchor SubstituteKazunori Ida, Noriyuki Sato, Satoshi Kawaguchi et al.|The Journal of Immunology|2004Cited by 32